IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 218 filers reported holding IMMUNOGEN INC in Q1 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,761,000 | -69.1% | 300,000 | -85.5% | 0.02% | -36.4% |
| Q4 2021 | $15,402,000 | +93.6% | 2,075,700 | +48.0% | 0.03% | +73.7% |
| Q3 2021 | $7,954,000 | -47.6% | 1,402,800 | -39.1% | 0.02% | -42.4% |
| Q2 2021 | $15,178,000 | +291.6% | 2,303,200 | +173.3% | 0.03% | +6.5% |
| Q2 2020 | $3,876,000 | +22.9% | 842,695 | -8.9% | 0.03% | -8.8% |
| Q1 2020 | $3,153,000 | +20.7% | 924,695 | +80.7% | 0.03% | +209.1% |
| Q4 2019 | $2,612,000 | – | 511,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
| CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
| Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
| RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
| Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
| Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
| Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
| QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
| Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |